IAMA Therapeutics
PrivateLast Round
Series B
Apr 16, 2025
Total Funding Raised
$25.83M
Company Overview
IAMA Therapeutics operates in Healthcare & Life Sciences and is based in Genoa. Its latest recorded funding round was a Series B round in April 2025.
IAMA Therapeutics is a biotechnology company that develops a neuroscience drug discovery platform to provide personalized treatments for patients suffering from untreatable neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IAMA Therapeutics Comparables
Compare IAMA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axonis Therapeutics | 81% | |
| GRIK Therapeutics | 80% | |
| Actio Biosciences | 79% |
For institutional investors. Book with your work email.
IAMA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 16, 2025 | ||||
| Series A | Mar 29, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IAMA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Indaco Venture Partners SGR | Series B |
| Claris Ventures | Series A, Series B |
| Cassa Depositi e Prestiti | Series A, Series B |
| CDP Venture Capital SGR | Series B, Series A |
| ENEA-Tech and Biomedical Foundation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2025
Torsten M. Madsen appointed as the new Chief Executive Officer.
- Sep 1, 2025
Torsten M. Madsen was dismissed in September 2025.
For institutional investors. Book with your work email.
IAMA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IAMA Therapeutics's valuation, stock price, and market status.
Is IAMA Therapeutics a public or private company?
IAMA Therapeutics is a private company.
What is the current stock price of IAMA Therapeutics?
IAMA Therapeutics is a private company, so its shares have no public market price. Caplight tracks IAMA Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IAMA Therapeutics worth (valuation)?
Valuation information for IAMA Therapeutics is not publicly available.
Can I buy IAMA Therapeutics stock?
IAMA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IAMA Therapeutics's last funding round?
IAMA Therapeutics's most recent funding round was Series B on April 16, 2025.
Who are the main investors in IAMA Therapeutics?
Key investors in IAMA Therapeutics include Indaco Venture Partners SGR, CDP Venture Capital SGR.
Will IAMA Therapeutics IPO soon?
No public IPO plans have been announced for IAMA Therapeutics.
How can I track IAMA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in IAMA Therapeutics's shares on secondary markets.